Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Journal for Immunotherapy of Cancer
|
May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events
Steven M Blum, Ben Ouyang, Leyre Zubiri, et al.
Oncogene
|
September 22, 2019
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors
Caitlin M O'Connor, Daniel Leonard, Danica Wiredja, et al.
Cell
|
April 22, 2020
Selective PP2A Enhancement through Biased Heterotrimer Stabilization
Daniel Leonard, Wei Huang, Sudeh Izadmehr, et al.
Cancer Research
|
May 31, 2019
The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis
Sarah E Taylor, Caitlin M O'Connor, Zhizhi Wang, et al.
Acta Chirurgica Belgica
|
June 5, 2026
Risk factors associated with urinary tract infection within 4 days of male rectal cancer surgery in the era of enhanced recovery after surgery (ERAS) programs
Jean-Luc Faucheron, Fatah Tidadini, Zaher Lakkis, et al.
Nature Communications
|
August 1, 2024
The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo
Michael H J Rhodin, Archie C Reyes, Anand Balakrishnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Carine El Sissy, Amos Kirilovsky, Marc Van den Eynde, et al.
The Journal of Clinical Investigation
|
May 16, 2017
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Jaya Sangodkar, Abbey Perl, Rita Tohme, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Journal for Immunotherapy of Cancer
|
May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events
Steven M Blum, Ben Ouyang, Leyre Zubiri, et al.
Oncogene
|
September 22, 2019
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors
Caitlin M O'Connor, Daniel Leonard, Danica Wiredja, et al.
Cell
|
April 22, 2020
Selective PP2A Enhancement through Biased Heterotrimer Stabilization
Daniel Leonard, Wei Huang, Sudeh Izadmehr, et al.
Cancer Research
|
May 31, 2019
The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis
Sarah E Taylor, Caitlin M O'Connor, Zhizhi Wang, et al.
Acta Chirurgica Belgica
|
June 5, 2026
Risk factors associated with urinary tract infection within 4 days of male rectal cancer surgery in the era of enhanced recovery after surgery (ERAS) programs
Jean-Luc Faucheron, Fatah Tidadini, Zaher Lakkis, et al.
Nature Communications
|
August 1, 2024
The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo
Michael H J Rhodin, Archie C Reyes, Anand Balakrishnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Carine El Sissy, Amos Kirilovsky, Marc Van den Eynde, et al.
The Journal of Clinical Investigation
|
May 16, 2017
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Jaya Sangodkar, Abbey Perl, Rita Tohme, et al.
Page
of 6